The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented?

被引:10
作者
Penuelas, Ivan [1 ]
Vugts, Danielle J. [2 ]
Decristoforo, Clemens [3 ]
Elsinga, Philip H. [4 ]
机构
[1] Clin Univ Navarra UNAV, IdiSNA, Dept Nucl Med, Radiopharm Unit, Pamplona, Spain
[2] Vrije Univ Amsterdam, Amsterdam Neurosci, Dept Radiol & Nucl Med, Med Ctr, Amsterdam, Netherlands
[3] Med Univ Innsbruck, Dept Nucl Med, Innsbruck, Austria
[4] Univ Groningen, Univ Med Ctr, Dept Nucl Med & Mol Imaging, Groningen, Netherlands
关键词
D O I
10.1186/s41181-019-0055-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页数:5
相关论文
共 4 条
[1]  
[Anonymous], 2018, EMACHMPSWP6861402018
[2]  
Decristoforo C, 2016, EJNMMI RADIOPHARM CH, V1, DOI 10.1186/s41181-016-0011-7
[3]  
Moberg Dave, 2014, THESE TIMES 0212
[4]   Main changes in European Clinical Trials Regulation (No 536/2014) [J].
Tenti, E. ;
Simonetti, G. ;
Bochicchio, M. T. ;
Martinelli, G. .
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2018, 11 :99-101